© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. Hot Topics In Clinical Research: Knowing the Risks, Applying the Law To ask a question during.

Slides:



Advertisements
Similar presentations
REFINING YOUR DISCOVERY TACTICS: A PLAINTIFF PERSPECTIVE Amanda A. Farahany Barrett & Farahany, LLP 1401 Peachtree Street, Suite 101 Atlanta, GA
Advertisements

Advanced Issues in HIPAA Research Compliance The Sixth National HIPAA Summit March 27, 2003 Kim P. Gunter Senior Consultant.
1 Ignacio de Castro WIPO Arbitration and Mediation Center Solving Disputes: The Services of the WIPO Arbitration and Mediation Center WIPO-INSME Training.
HIPAA Privacy Practices. Notice A copy of the current DMH Notice must be posted at each service site where persons seeking DMH services will be able to.
VCOM Conflict of Interest Policy Overview of Financial Conflict of Interest Related to Research December 4, 2013.
Stark Scenarios: How the 2009 MPFS and IPPS Final Rules Affect Your Hospital and Practice Welcome to the meeting. Today’s presentation will begin at.
UWG Contract Compliance 101 Goal of Presentation Learn how to successfully read, understand and complete a contract associated with the procurement of.
Let’s Study Legal English Together!
USC Clinical Trials Office (CTO) Answers to CTOs who, what, when, and how questions Soheil Jadali Director, Clinical Trial Office.
WHAT TO EXPECT IN AN EXTERNAL AUDIT OR INVESTIGATION An Overview of External Audit and Investigative Processes Performed by Outside Entities at UCSD.
Managing Conflicts of Interest
Documentation and Maintenance of Records What You Should Know and Why Program Training For Medicaid Providers of Home and Community Care Services Home.
Clinical Trial Agreements
1 The HIPAA Privacy Rule and Research This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep.
Presentation before the Missouri Bar’s Health and Hospital Law Committee November 18, 2011 Markus P. Cicka, J.D., L.L.M. (Health Law) Director – Missouri.
HIPAA Privacy Rule Training
COMPLYING WITH HIPAA PRIVACY RULES Presented by: Larry Grudzien, Attorney at Law.
Through 2008 Season Barry Bonds 762 Home Runs Roger Clemens 354 Wins Alex Rodriguez 553 Home Runs.
Health Insurance Portability Accountability Act of 1996 HIPAA for Researchers: IRB Related Issues HSC USC IRB.
Clinical Research Billing and CMS Coverage Analysis Challenges CCAF Spring 2014 Conference Beverly Ginsburg Cooper Senior Director and Lead, Cancer Center.
© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. Section Are You Ready for the New CMS Reporting Requirements? Presented by: Erin S. Zuiker.
2011 FRAUD & ABUSE UPDATE John Hellow Hooper, Lundy & Bookman, PC All views expressed in the seminar materials and.
The New Mediation Regulation October 16, 2012 Commissioner Derrick L. Williams.
Sales & Marketing Compliance Training
Institutional Compliance with the NIH Public Access Policy: Ensuring Deposit Rights, March 7, 2008 Sponsored by The Association of Research Libraries (ARL)
Contract Negotiation Basics for Sponsored Programs
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
NIH Proposed Use of a Central IRB (C-IRB) for NIH-funded multi-site studies Committee on Clinical Research January 26,
© 2011 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. Challenges in Clinical Research Trials Christee G. Laster Smith Moore Leatherwood LLP 1180 W.
©2012 PhramaSeek Financial Services, LLC Navigating Medicare Billing Guidelines in Clinical Trials.
Notice of Privacy Practices Nebraska SNIP Privacy Subgroup July 18, 2002 Michael J. Brown, MHA, CPA Vice-President, Administrative & Regulatory Affairs,
Trends Regarding Disputes in the Health Care Industry To ask a question during the presentation, click the Q&A menu at the top of this window, type your.
Contracts: Negotiations and Key Elements Belinda Vandersluis Operations Director, NCIC CTG.
Compliance Todd Phillips Thousand Cranes. INTERNAL MONITORING AND AUDITING GOAL In order to ensure the efficacy of Thousand Cranes Compliance efforts,
The Contracting Process (Why Does it Take So Long?) Libby Salberg, Associate Director Beth Watkins, Contract Analyst, Team Manager Janet Fry, Manager Clinical.
MANAGING SPONSORED PROJECTS FINANCIAL COMPLIANCE May 1, 2008 Office of Grants &Contracts Accounting.
New Faculty Orientation August 22, 2012 UAMS Research Support Center Director: Tom Wells (501)
CONFIDENTIAL © 2014 Barnes & Thornburg LLP. All Rights Reserved. This page, and all information on it, is confidential, proprietary and the property of.
Presented by David P. Schack, Partner June 29, 2006 Insurance Coverage For Multi- State Investigations: Can You Get Your Insurer to Pay for.
Key Compliance Risks in Clinical Trials Kathleen Meriwether Principal, ERNST & YOUNG, LLP Fraud Investigation & Dispute Services.
1 Investigating Fraud & Abuse Violations in Medical Research Janet Rehnquist, Esq. Venable LLP th Street, NW Washington, DC
Medical Law and Ethics, Third Edition Bonnie F. Fremgen Copyright ©2009 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved.
Health Insurance Portability and Accountability Act (HIPAA) CCAC.
© 2013 The McGraw-Hill Companies, Inc. All rights reserved. Ch 8 Privacy Law and HIPAA.
Training II: Software, Publications, IP, and Export Control Issues L. Meixler Many researchers tend not to regard software as IP. They often share software.
A Primer on Clinical Trials for the Research Administrator
Scholarly Publication: Responsibilities for Authors and Reviewers Jean H. Shin, Ph.D. Director, Minority Affairs Program American Sociological Association.
Copyright ©2014 by Saunders, an imprint of Elsevier Inc. All rights reserved 1 Chapter 02 Compliance, Privacy, Fraud, and Abuse in Insurance Billing Insurance.
Melissa McCarey, MPH Jefferson Clinical Research Institute (JCRI) Clinicaltrials.gov: What is it? What do I need to know?
Business Operations Pre-Award. What is required to begin the business process? Possible indicators CDA executed Cancer Center MDG/PRC approvals Department.
PRESENTED BY: Cherron Payne, Esq., Office of Clinical and Translational Research Dowling North, Second Floor Ext CONTRACT PROCEDURE.
Top 10 Legal Minefields A University Perspective October 8, 2009 Catherine Shea Associate University Counsel University of Colorado.
Click to edit Master title style Compliance Plan Improvement For Health Systems Presented By: Scott Becker, Partner,
1 Risk Management Bonding & Insurance Jimmy Porter Risk Analyst City of Atlanta.
Business Operations Pre-Award. Confidential Disclosure Agreements (CDA)/ Non-Disclosure Agreements (NDA)
Regulation Highlights Kimberly Heifetz May 15, 2012.
PREPARED BY: SUZAN BRUCE, CPC CLINICAL TRIALS OFFICE, UC DAVIS 1 Clinical Research Billing & Coding.
Wisconsin Department of Health Services Purchase of Services Contract Guide Julie Anstett and Lucinda Champion Friday, May 6, 2016 Wisconsin Department.
HIPAA Training Workshop #3 Individual Rights Kaye L. Rankin Rankin Healthcare Consultants, Inc.
Four Ways Suppliers Limit Their Risk Contractually
Clinical Trial Billing and Patient Remuneration
HIPAA Privacy Rule Training
ClinicalTrials.gov Requirements
What is HIPAA? HIPAA stands for “Health Insurance Portability & Accountability Act” It was an Act of Congress passed into law in HEALTH INSURANCE.
Clinical Trial Contracts Office -What’s the Hold Up?
Analysis of the Proposed Sunshine Rule: Legal Considerations
Export Controls – Export Provisions in Research Agreements
Open Access and Compliance with NIH Public Access Policy
The HIPAA Privacy Rule and Research
Clinical Trial Agreements (CTAs): Standard Terms and Conditions
Presentation transcript:

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. Hot Topics In Clinical Research: Knowing the Risks, Applying the Law To ask a question during the presentation, click the Q&A menu at the top of this window, type your question in the Q&A text box, and then click Ask. After you click Ask, the button name will change to Edit. Questions will be queued and most will be answered at the end of the meeting as time allows. Molly Huggins Smith Moore Leatherwood LLP 2800 Two Hannover Square Raleigh, NC T: (919) Presented by: Christee Laster Smith Moore Leatherwood LLP 1180 West Peachtree Street NW, Suite 2300 Atlanta, GA T: (404)

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® On the Menu Today: I.Publication II.Conflicts of Interest III.Medicare Billing

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication: Issues and Considerations Tax status of Institution and compliance therewith. Investigator publication expectations. Compliance with journal requirements.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication: Issues and Considerations Sponsors interest in protecting confidential or proprietary information. Sponsors interest in proper completion of the Study. Accuracy and integrity of publications.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication Rights: Building the Contract Provision Step 1: Do you need the right to publish the study results? If so, affirm the right to publish. Upon completion of the Study, Institution and Investigator shall have the right to publish the results of the Study in accordance with the terms of this Agreement.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication Rights: Building the Contract Provisions Step 2: Permit Sponsor an opportunity to review and comment, but Institution/Investigator should retain editorial control. Institution or Investigator shall provide Sponsor with a copy of any proposed publication or presentation at least thirty (30) days in advance of submission to a journal, editor, or other third party. Sponsor shall have thirty (30) days to respond with any comments or requested revisions. Institution and Investigator shall consider the requested revisions in good faith.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication Rights: Building the Contract Provisions Caution! Do you see the problem with these provisions? Section A: Confidentiality. Confidential Information shall mean information disclosed by Sponsor to Institution under this Agreement and any and all information arising from performance of the Study. Section B: Publication. Sponsor shall have the right to require the removal of any Confidential Information from the proposed publication.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication Rights: Building the Contract Provision Be careful to ensure that the contract does not contradict itself. Suggested work arounds: (1) Sponsor shall have the right to require the removal of any Confidential Information from the proposed publication, other than Study results and background information required for publication.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication Rights: Building the Contract Provision or (2) Confidential Information shall mean information disclosed by Sponsor to Institution under this Agreement and any and all information arising from performance of the Study, other than Study results published in accordance with the terms of this Agreement.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication Rights: Building the Contract Provision Step 3: Provide Sponsor with an opportunity to take steps to protect proprietary information. If Sponsor determines that the proposed publication or presentation contained patentable or otherwise proprietary information that requires protection, Institution and Investigator shall delay the publication or presentation for up to an additional sixty (60) days to permit Sponsor an opportunity to seek such protection.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication Rights: Building the Contract Provisions Step 4: If applicable, account for multi-center studies. Because this is a multi-center Study, Institution and Investigator shall not publish their sites Study results until the publication or presentation of the multi-center results. Notwithstanding the foregoing, if a multi-center publication is not submitted for publication within twelve (12) months after the conclusion, abandonment, or termination of the Study at all sites, or upon Sponsor notice that there will be no multi-center publication, Institution or Principal Investigator may publish the Study results as set forth herein.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication Rights: Building the Contract Provisions Common question: When is a Study completed at all sites? Alternatives: –Database lock (preferred) –Specific date

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication Rights: Building the Contract Provisions What time period is reasonable: 12 months, 18 months, 24 months? Document: –Number of sites –Number of expected subjects –Complexity of analysis

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Publication Rights: Final Considerations Preserve publication opportunities: –Require registration of Study on a public clinical trials registry –Require compliance with ICJME guidelines –Reserve copyright ownership of all publications

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Conflicts of Interest Everyones Watching: –IOM reports –OIG reports –Sen. Grassley! Understanding the Conflict: –Know the Rules/Standards: NIH/FDA/NSF AAMC/AAU

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Conflicts of Interest Nature of the Conflict: –Consulting fees –Payments for recruiting subjects –Travel expenses –Royalties or other IP interests –Credit for published works

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Conflicts of Interest Whats at Stake? Suspension of research funding Risk to human subjects Anti-Kickback violations Litigation Professional reputation False Claims Act liability, as amended Physician Payments Sunshine Act of 2009

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Conflicts of Interest Managing Conflicts: –Infrastructure Create the internal policies … and follow through Know who, when and how Communicate enforcement protocols Require disclosure on an ongoing basis Internal, random audits Acknowledge and report noncompliance

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. The Big Picture: Why Getting It Right Matters to Institutions The False Claim Act (31 U.S.C. §§ and 42 U.S.C. § 1320A-7a(a)) imposes criminal and civil liability for submitting false claims to the federal government for payment. Civil penalties range from $5,000 - $11,000 per claim, trebled. Criminal penalties can be up to 5 years imprisonment, $25,000 fine, and mandatory expulsion from Medicare.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. The Big Picture: Why Getting It Right Matters to Institutions Improper submission of a claim for items and services provided pursuant to a clinical trial can subject the institution to allegations of submitting false claims. This is an area of high internal scrutiny within institutions. Not an area where many institutions are willing to take the risk of getting it wrong.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. Medicare Billing: The Basics The fundamental rule: Medicare may be billed for items and services provided during a clinical trial that constitute routine billable costs. Medicare should not be billed for standard of care items and services. Standard of care and Routine Billable Costs are not the same.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. Suggestions Research finance department should perform a Medicare coverage analysis for every clinical trial. Address those items and services that do not constitute routine billable costs in budget negotiations at the front end.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. Budget Negotiations: A Common Hurdle Investigational Items and Services For those items and services that the institution determines are investigational in its Medicare coverage analysis, should the institution take a bill first approach before billing the sponsor? Doing so incurs risk of FCA violation.

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Questions?

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Please join us for our next Hot Topics segments: –Subject Injury & Medicares Secondary Payor Rule –O.I.G. Enforcement

© 2009 Smith Moore Leatherwood LLP. ALL RIGHTS RESERVED. ® Molly Huggins Smith Moore Leatherwood LLP 434 Fayetteville Street, Suite 2800 Raleigh, NC T: (919) F: (919) Christee Laster Smith Moore Leatherwood LLP 1180 West Peachtree Street NW, Suite 2300 Atlanta, GA T: (404) F: (404)